According to analysts from Danske Bank, the difference between the Federal Reserve (Fed) and the Reserve Bank of Australia (RBA) will likely weigh on the Australian dollar. They forecast AUD/USD at 0.72 in a one-month period and at 0.71 in six months.
“AUD has appreciated over the past month despite the record-high infections of the omicron-variant, as Australia’s new Covid-strategy has entailed only very light restrictions relative to the earlier lockdowns.”
“Renewed stimulus in China has supported Australian terms-of-trade, as prices of its key export commodity, iron ore, have recovered moderately on the back of more positive demand outlook. Broad USD weakening has also contributed to higher AUD/USD and stronger commodity prices, although we still think the move is unlikely to last.”
“The Reserve Bank of Australia could potentially end its QE purchases in February, although the omicron-driven combination of weaker consumption and staff shortages complicate the decision. However, with strong recovery in Australian labour force, dovish RBA communication and four hikes already priced in for 2022, we think relative monetary policy is generally likely to weigh on AUD later this year.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.